The purpose of student discussions is to provide the opportunity for deeper understanding of polypharmacy
Activity Learning Outcomes
Through this discussion, the student will demonstrate the ability to:
- Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1)
- Discuss polypharmacy risk factors (WO1.5) (CO1)
- Explain thee actions steps for polypharmacy prevention (WO1.5) (CO1, 7)
The initial posting to the graded collaborative discussions is due by Wednesday, 11:59 p.m. MT.
Peer responses and responses to faculty must be posted prior to the week deadline of Sunday 11:59 MT.
A 10% late penalty will be imposed for discussions posted after the deadline on Wednesday, regardless of the number of days late. NOTHING will be accepted after 11:59pm MT on Sunday (i.e. student will receive an automatic 0).
Total Points Possible:
Your initial discussion post should include the following:
- Identify and discuss 2-3 definitions of polypharmacy (there are multiple definitions). Your textbook can count as 1 reference. You must also include an additional reference from an evidence-based practice journal article or national guideline.
- Identify three risk factors that can lead to polypharmacy. Explain the rationale for why each listed item is a risk factor. Risk factors are different than adverse drug reactions.ADRs can be a result of polypharmacy, and is important, but ADRs are not a risk factor.
- Explore three action steps that a provider can take to prevent polypharmacy.
- Provide an example of how your clinical preceptors have addressed polypharmacy.